Salud financiera de hoja de balance de Organon
Salud financiera controles de criterios 1/6
Organon tiene un patrimonio de accionistas total de $493.0M y una deuda total de $8.7B, lo que sitúa su ratio deuda-patrimonio en 1774.6%. Sus activos y pasivos totales son $12.8B y $12.3B respectivamente. El BAIT de Organon es de $1.5B, por lo que su ratio de cobertura de intereses es de 2.9. Tiene efectivo e inversiones a corto plazo que ascienden a $763.0M.
Información clave
1,774.6%
Ratio deuda-patrimonio
US$8.75b
Deuda
| Ratio de cobertura de intereses | 2.9x |
| Efectivo | US$763.00m |
| Patrimonio | US$493.00m |
| Total pasivo | US$12.26b |
| Activos totales | US$12.75b |
Actualizaciones recientes sobre salud financiera
Recent updates
The Organon & Co. (NYSE:OGN) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Nov 04
Roivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic Dermatitis
Sep 19These 4 Measures Indicate That Organon (NYSE:OGN) Is Using Debt In A Risky Way
Sep 13Organon & Co.: Cheap With Caveats
Aug 22Organon (NYSE:OGN) Will Pay A Dividend Of $0.28
Aug 09Insufficient Growth At Organon & Co. (NYSE:OGN) Hampers Share Price
Aug 07Organon: Upcoming Q2 Earnings Can Sustain Upward Momentum
Jul 30Organon & Co.'s (NYSE:OGN) CEO Might Not Expect Shareholders To Be So Generous This Year
May 29Organon's (NYSE:OGN) Solid Profits Have Weak Fundamentals
May 10Four Reasons Why Organon Stock Is A Good Buy
May 07Little Excitement Around Organon & Co.'s (NYSE:OGN) Earnings
Apr 21Organon Stock Is Still Worth A Look
Feb 24Organon (NYSE:OGN) Is Due To Pay A Dividend Of $0.28
Feb 19Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last
Feb 16Organon: What I'm Looking For In This 8% Yield In 2024
Jan 03High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued
Dec 19Organon: It's Darkest Before The Dawn
Nov 30Organon: Poor Q3 Earnings Make Bear Case, But Dividend Is Saving Grace
Nov 07Organon (NYSE:OGN) Has Affirmed Its Dividend Of $0.28
Nov 05Organon: The Federal Reserve Black Swan (Rating Upgrade)
Oct 046% Yield And Significantly Undervalued: A Closer Look At Organon
Sep 10Organon Q2 2023 Earnings Review: Incremental Growth With A Slather Of Risk
Aug 10Organon & Co.: A Tough Spot To Be In Right Now
Jul 16Organon goes ex-dividend tomorrow
Feb 23Organon & Co. (NYSE:OGN) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Feb 19Is There Anything Organic Or Interesting About Organon?
Feb 07Organon goes ex-dividend tomorrow
Nov 09Organon's (NYSE:OGN) Dividend Will Be $0.28
Nov 08Take Care Before Diving Into The Deep End On Organon & Co. (NYSE:OGN)
Nov 05Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($4.8B) de OGN superan a sus pasivos a corto plazo ($2.8B).
Pasivo a largo plazo: Los activos a corto plazo ($4.8B) de OGN no cubren sus pasivos a largo plazo ($9.5B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de OGN (1619.9%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de OGN ha crecido de 2.6% a 1774.6% en los últimos 5 años.
Cobertura de la deuda: La deuda de OGN no está bien cubierta por el flujo de caja operativo (10.8%).
Cobertura de intereses: Los pagos de intereses de la deuda de OGN no están bien cubiertos por el BAIT (2.9x cobertura).